AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

Clinical trial NCT01474135 · COMPLETED

Trial details

NCT number: NCT01474135
Sponsor: Aerie Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2011-12-01
Primary completion: 2012-04-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.